Literature DB >> 7872159

Immune response against tumors.

C Roth1, C Rochlitz, P Kourilsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7872159     DOI： 10.1016/s0065-2776(08)60675-6

Source DB:  PubMed          Journal:  Adv Immunol        ISSN： 0065-2776            Impact factor:   3.543


× No keyword cloud information.
  9 in total

Review 1.  Gene therapy for liver diseases: recent strategies for treatment of viral hepatitis and liver malignancies.

Authors:  V Schmitz; C Qian; J Ruiz; B Sangro; I Melero; G Mazzolini; I Narvaiza; J Prieto
Journal:  Gut       Date:  2002-01       Impact factor: 23.059

Review 2.  Cancer gene and immunotherapy: recent developments.

Authors:  P Jantscheff; R Herrmann; C Rochlitz
Journal:  Med Oncol       Date:  1999-07       Impact factor: 3.064

Review 3.  Immunosuppression in human tumor-host interaction: role of cytokines and alterations in signal-transducing molecules.

Authors:  R Kiessling; K Kono; M Petersson; K Wasserman
Journal:  Springer Semin Immunopathol       Date:  1996

Review 4.  The role of cytotoxic T-lymphocytes in the prevention and immune surveillance of tumors--lessons from normal and immunodeficient mice.

Authors:  I M Svane; M Boesen; A M Engel
Journal:  Med Oncol       Date:  1999-12       Impact factor: 3.064

5.  Identification of a new HLA-A*0201-restricted CD8+ T cell epitope from hepatocellular carcinoma-associated antigen HCA587.

Authors:  B Li; Y Wang; J Chen; H Wu; W Chen
Journal:  Clin Exp Immunol       Date:  2005-05       Impact factor: 4.330

6.  A tumor-suppressor function for Fas (CD95) revealed in T cell-deficient mice.

Authors:  S L Peng; M E Robert; A C Hayday; J Craft
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

Review 7.  Delayed Effect of Dendritic Cells Vaccination on Survival in Glioblastoma: A Systematic Review and Meta-Analysis.

Authors:  Salvatore Cozzi; Masoumeh Najafi; Marzieh Gomar; Patrizia Ciammella; Cinzia Iotti; Corrado Iaccarino; Massimo Dominici; Giacomo Pavesi; Chiara Chiavelli; Ali Kazemian; Amin Jahanbakhshi
Journal:  Curr Oncol       Date:  2022-02-04       Impact factor: 3.677

8.  Molecular cancer vaccines: Tumor therapy using antigen-specific immunizations.

Authors:  T Schweighoffer
Journal:  Pathol Oncol Res       Date:  1997-09       Impact factor: 2.874

9.  Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo.

Authors:  P Paglia; C Chiodoni; M Rodolfo; M P Colombo
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.